| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA657454 | F | Compound was tested for its ability to inhibit camptothecin-resistant variant cell line (CPT-K5) derived from RPMI 8402 | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 2. | ALA657455 | F | Cytotoxicity towards camptothecin resistant CPT-K5 cell line in human | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 3. | ALA658281 | F | Cytotoxicity using camptothecin-resistant variant of RPM18402 (CPT-K5) possessing functional, but mutant TOP-1 | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 4. | ALA884097 | F | Cytotoxicity against Camptothecin-resistant (CPT -K5) cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA658282 | F | Cytotoxicity against Camptothecin-resistant (CPT -K5) cell line. | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 6. | ALA770794 | F | Cytotoxicity against human lymphoblast tumor cell line RPM18402 | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
| 7. | ALA770801 | F | Compound was tested for its ability to inhibit RPMI 8402 human lymphoblast tumor cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 8. | ALA770802 | F | Cytotoxicity towards lymphoblastoma (RPMI 8402) cells in human | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 9. | ALA857427 | F | Cytotoxicity using human lymphoblast RPMI 8402 cells. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 10. | ALA770686 | F | Cytotoxicity against Human lymphoblast (RPMI 8402) cell line | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 11. | ALA770687 | F | Cytotoxicity against human lymphoblast cell line RPMI 8402 | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
| 12. | ALA770850 | F | Cytotoxic activity against human lymphoblast tumor cell line RPMI8402 after 4 days of treatment | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
| 13. | ALA832521 | F | Cytotoxicity against camptothecin-resistant RPMI 8402 | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 14. | ALA834677 | F | Concentration required to inhibit cell proliferation in RPM18402 tumor cell line | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 15. | ALA825082 | F | Inhibitory concentration against lymphoblast RPMI 8402 cell line was determined | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 16. | ALA837459 | F | Concentration required to inhibit cell proliferation in CPT-K5 tumor cell line; camptothecin resistant | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
| 17. | ALA865508 | A | Uptake in human RPMI8402 cells at 1 uM after 0.5 hrs | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA865509 | A | Uptake in human RPMI8402 cells at 1 uM after 1 hr | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA865510 | A | Uptake in human RPMI8402 cells at 1 uM after 2 hrs | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA865511 | A | Uptake in human RPMI8402 cells at 1 uM after 4 hrs | Homo sapiens | 2 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!